Dexamethasone Sodium PhosphateThird Party Manufacturing in India

Dexamethasone Sodium Phosphate is a highly potent synthetic glucocorticoid that exerts powerful anti-inflammatory and immunosuppressive effects. It works by diffusing across cell membranes and binding with high affinity to cytoplasmic glucocorticoid receptors. The activated receptor-ligand complex then translocates into the cell nucleus, where it binds to specific DNA sequences known as glucocorticoid response elements. This interaction leads to the transactivation of genes encoding anti-inflammatory proteins, such as lipocortin-1 (annexin-1), which inhibits phospholipase A2. By blocking phospholipase A2, dexamethasone prevents the release of arachidonic acid, the precursor for inflammatory mediators like prostaglandins and leukatrienes.

Simultaneously, the receptor complex suppresses the transcription of pro-inflammatory genes through transrepression, directly interfering with key transcription factors like nuclear factor-kappa-B (NF-κB) and activator protein-1 (AP-1). This leads to a marked reduction in the expression of inflammatory cytokines, including interleukin-1, interleukin-6, and tumor necrosis factor-alpha, as well as cell adhesion molecules and cyclooxygenase-2. Dexamethasone also reduces capillary permeability, inhibits leukocyte migration to the site of inflammation, and stabilizes lysosomal membranes to prevent tissue damage. Its glucocorticoid activity is approximately 25 to 30 times more potent than hydrocortisone, with minimal mineralocorticoid activity, making it ideal for severe inflammatory states.

Our services for Dexamethasone Sodium Phosphate third party manufacturing in India provide high-quality sterile injectables in various strengths to satisfy domestic and international clinical requirements.

Therapeutic Uses

Dexamethasone Sodium Phosphate injection is prescribed for the treatment of:

• Severe Allergic Reactions: Controls acute, self-limiting allergic conditions such as anaphylaxis, angioedema, status asthmaticus, and severe drug reactions.
• Inflammatory Disorders: Alleviates intense inflammation in acute gouty arthritis, rheumatoid arthritis, systemic lupus erythematosus, and acute tenosynovitis.
• Cerebral Edema: Reduces intracranial pressure associated with primary or metastatic brain tumors, craniotomy, or head injury.
• Endocrine Disorders: Used for adrenal insufficiency and congenital adrenal hyperplasia, or as a diagnostic screening test for Cushing's syndrome.
• Shock: Serves as adjunctive therapy in severe shock (e.g., septic or hemorrhagic shock) unresponsive to standard fluid and vasopressor therapy.

Why Manufacturers Choose Dexamethasone Sodium Phosphate

Dexamethasone Sodium Phosphate is one of the most widely used glucocorticoid injections globally, featured on the WHO Model List of Essential Medicines. The 4mg/2ml and 8mg/2ml injectable forms are vital clinical staples in emergency care, critical care, and oncology wards. Indian manufacturers produce this sterile liquid formulation under strict aseptic conditions, ensuring excellent stability and bioequivalence.

For third party distributors and PCD franchise operators, Dexamethasone Sodium Phosphate injection offers high and consistent order volumes, driven by constant hospital demand. Sourcing from WHO-GMP certified facilities ensures compliance with international quality standards, supporting seamless distribution in domestic and export markets. You can learn more about our contract manufacturing operations or view our manufacturing listings. Feel free to contact us to discuss your specific requirements.